Marketing Pharma Companies Regulation Vaccination 
World of DTC Marketing
FEBRUARY 21, 2022
Pfizer expects to make as much as $22bn from its new Covid pill this year, on top of $37bn it made in 2021 from the vaccine. The study adds further evidence to the idea that drug copay cards are a great short-term deal for patients — and especially the pharma companies that promote them — but a wrong long-term value for healthcare costs.
World of DTC Marketing
DECEMBER 9, 2020
Pfizer is having supplier issues, some people who received the vaccine are reporting side effects like Bell’s Palsy. In the meantime this administration is patting itself on the back for the quick development of vaccines. What assurances does the public have that every dose of vaccine is made to the highest quality standards?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
World of DTC Marketing
FEBRUARY 28, 2021
SUMMARY: Pharma companies, like J&J, have received criticism for engaging in illegal activities, such as providing kickbacks and bribes, knowingly shipping adulterated or contaminated drugs to pharmacies, and marketing drugs for unapproved uses. Can a COVID-19 vaccine approval suddenly erase that? The answer is NO.
World of DTC Marketing
SEPTEMBER 11, 2020
IN SHORT: Pharma companies have finally banded together to ask the FDA to better regulate any new drug approvals including a possible new COVID vaccine. And only about 4 in 10 would get the vaccine, even if it were free if the FDA approved it before the election. Big pharma is clearly worried.
BioPharma Reporter
NOVEMBER 18, 2020
While governments are now getting ready to ensure large-scale, equitable access and distribution of a COVID-19 vaccine, concern about vaccine hesitancy is growing worldwide. The COVID-19 pandemic is expected to continue to impose enormous burdens on societies and economies globally.
BioPharma Reporter
FEBRUARY 2, 2021
Rows about vaccine supply and threats of export blocks donât do anything to bring us closer to ending the COVID-19 pandemic, say campaigners pushing for vaccine equity on a global level.
BioPharma Reporter
MARCH 23, 2021
The pharma company and the CDC are recommending that adults continue routine vaccination during the COVID-19 pandemic to reduce future vaccine-preventable disease (VPD) outbreaks and overall strain on the healthcare system.
Expert insights. Personalized for you.
218 
Let's personalize your content